A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT05866692 · RECRUITING

Trial details

NCT number: NCT05866692
Sponsor: TYK Medicines, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2023-08-17
Primary completion: 2025-10-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.